When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
APTO - Aptose to launch early-stage CG-806 study in acute myeloid leukemia
Aptose Biosciences Inc.
Aptose Biosciences (NASDAQ:APTO) is up 7% premarket in reaction to its announcement that the FDA has signed off on its IND application to initiate a Phase 1a/b clinical study of CG-806, an oral FLT3/BTK inhibitor, in patients with acute myeloid leukemia (AML).
More news on: Aptose Biosciences Inc., Healthcare stocks news, Stocks on the move,